- Report
- February 2025
- 200 Pages
Global
From €4110EUR$4,490USD£3,493GBP
- Report
- May 2025
- 67 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 287 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 1417 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 158 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 194 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- May 2025
- 181 Pages
Global
From €5355EUR$5,850USD£4,551GBP
- Report
- January 2025
- 183 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- November 2024
- 180 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- August 2024
- 185 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- June 2024
- 185 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- April 2025
- 115 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- April 2025
- 111 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- April 2025
- 120 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1831EUR$2,000USD£1,556GBP
- Report
- April 2025
- 110 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- April 2025
- 120 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- August 2024
- 150 Pages
Global
From €3433EUR$3,750USD£2,917GBP
- Report
- July 2024
- 150 Pages
Global
From €3433EUR$3,750USD£2,917GBP
- Report
- July 2024
- 150 Pages
Global
From €3433EUR$3,750USD£2,917GBP

Severe Acute Respiratory Syndrome (SARS) is a contagious respiratory illness caused by a virus. Diagnostics for SARS involve laboratory tests to detect the virus or its genetic material in a sample taken from the patient. Diagnostic tests for SARS include reverse transcription-polymerase chain reaction (RT-PCR), antigen-capture enzyme-linked immunosorbent assay (ELISA), and nucleic acid hybridization. These tests are used to detect the presence of the virus in a patient's sample and to differentiate between SARS and other respiratory illnesses.
Diagnostics for SARS are important for early detection and treatment of the disease. Early diagnosis and treatment can reduce the severity of the illness and prevent its spread. Diagnostics for SARS are also used to monitor the spread of the virus and to track its evolution.
Companies in the SARS diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more